Stereoselective synthesis and preliminary evaluation of (+)- and (–)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist

This publication has 25 references indexed in Scilit:

• Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?
  Neuropharmacology, 2002
• Metabotropic glutamate receptors: targets for therapy of cerebral ischaemia
  Emerging Therapeutic Targets, 2001
• 1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo[1.1.1] pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia
  European Journal of Neuroscience, 1999
• Reversal of glutamate excitotoxicity by activation of PKC‐associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression
  European Journal of Neuroscience, 1999
• Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors
  Published by Elsevier ,1999
• (S)-4C3HPG reduces infarct size after focal cerebral ischemia
  Neuropharmacology, 1998
• Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?
  Trends in Pharmacological Sciences, 1998
• The mGlu receptor ligand (S)-4C3HPG protects neurons after global ischaemia in gerbils
  NeuroReport, 1998
• Functional coupling between ryanodine receptors and L-type calcium channels in neurons
  Nature, 1996
• The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
  Neuropharmacology, 1995